Drug Delivery Systems Market Research Reports & Industry Analysis

The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit. Slow progress in the efficacy of the treatment of severe diseases suggests a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, biorecognition, and efficacy of drugs were generated. These new strategies, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, and molecular biology. A drug delivery system can be administered in a variety of ways. These routes of administration can be transdermal or transmucosal, or through the gastrointestinal tract and is often termed enteral or enteric administration. Many drugs as tablets, capsules, or drops are taken orally. The choice of a delivery route is determined by patient acceptability, the properties of the drug, its access to a disease location, or effectiveness. The most important drug delivery route is the peroral route. An increasing number of drugs are protein- and peptide-based. They offer the greatest potential for more effective therapeutics, but they do not easily cross mucosal surfaces and biological membranes; and are easily degraded and at present, protein drugs are usually administered by injection.
...Show More ...Show Less


Drug Delivery Systems Industry Research & Market Reports

  • Healthcare Dispensing Systems Market by Type (Automatic, Manual, Dispensing Component, Control System), Material (Reagent, Antibody, Powder), Application (Drug Delivery, Microfluidics), End User (Hospital, Pharmacy) & Region - Global Forecast to 2030

    ... and efficiency in life sciences and clinical applications drives pharmaceutical and biotechnology companies to shift toward high-throughput screening and personalized medicine. As a result, there is a rising need for accurate and contamination-free liquid handling ... Read More

  • The 2026-2031 World Outlook for Novel Drug Delivery Systems in Cancer Therapies

    ... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More

  • The 2026-2031 World Outlook for Closed System Transfer Devices

    ... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More

  • The 2026-2031 World Outlook for Medical Drug Delivery Disposables

    ... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More

  • The 2026-2031 World Outlook for Drug-Device Combination

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Drug Delivery across Blood Brain Barriers

    ... the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. ... Read More

  • The 2026-2031 World Outlook for Drug Delivery Technologies

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • The 2026-2031 World Outlook for Intrathecal Pumps

    ... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More

  • The 2026-2031 World Outlook for Advanced Drug Deliveries

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • Advanced Drug Delivery Systems – A Global Market Overview

    ... drug delivery, enhancing therapeutic outcomes while minimizing adverse effects. These systems improve drug solubility, bioavailability, and therapeutic effects while reducing side effects and dosing frequency, thus improving patient compliance and health outcomes. ADDS utilizes various ... Read More

  • Needle-Free Devices: Technologies and Global Markets

    ... performance. Analyses of the most popular products, clinical trials, new product approvals, and emerging technologies are also included. The market prospects for five regions—North America, Europe, Asia-Pacific, South America, and the Middle East and Africa ... Read More

  • Global Drug Delivery Devices Market - 2025-2033

    ... period 2025-2033. The global drug delivery devices market is undergoing rapid evolution, driven by technological innovation, the rising burden of chronic diseases, and a stronger focus on patient-centered care. Advanced solutions such as smart inhalers, ... Read More

  • Controlled Release Drug Delivery

    ... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Feedback Regulated, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$26.3 Billion by the ... Read More

  • Intranasal Drug Delivery

    ... at a CAGR of 6.7% over the analysis period 2024-2030. Liquid Delivery Devices, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$38.2 Billion by the end ... Read More

  • Polycaprolactone

    ... 8.3% over the analysis period 2024-2030. Coating & Thermoplastic polyurethane (TPU), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$141.2 Million by the end of the ... Read More

  • Novel Drug Delivery Systems (NDDS)

    ... Billion by 2030, growing at a CAGR of 21.9% over the analysis period 2024-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 21.4% CAGR and reach US$51.9 Billion by ... Read More

  • Nasal Drug Delivery Technology

    ... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Nasal Sprays, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$66.9 Billion by the ... Read More

  • Intrathecal Pumps

    ... CAGR of 5.1% over the analysis period 2024-2030. Morphine, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$115.9 Million by the end of the analysis period. ... Read More

  • Connected Drug Delivery Devices

    ... 2030, growing at a CAGR of 21.5% over the analysis period 2024-2030. Standalone Components & Software, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$14.8 Billion ... Read More

  • Bio-MEMS Devices

    ... CAGR of 16.7% over the analysis period 2024-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis period. ... Read More

  • Bio-MEMS

    ... 16.7% over the analysis period 2024-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$27.4 Billion by the end of the analysis period. Growth ... Read More

  • Drug Eluting Balloons (DEBs)

    ... 2030, growing at a CAGR of 11.5% over the analysis period 2024-2030. Peripheral, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$1.9 Billion by the end ... Read More

  • Electronic Drug Delivery Systems

    ... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Wearable Infusion Pumps, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$8.7 Billion by ... Read More

  • Nanotechnology in Drug Delivery

    ... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$35.6 Billion by the end ... Read More

  • Closed System Transfer Devices

    ... 2030, growing at a CAGR of 19.9% over the analysis period 2024-2030. Membrane-to-Membrane Systems, one of the segments analyzed in the report, is expected to record a 20.7% CAGR and reach US$4.4 Billion by the ... Read More

< prev 1 2 3 4 5 6 7

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings